Shook Shorts

Shook Partner Adrienne Byard and Of Counsel Kristin Kaplan discuss predictions for the Food and Drug Administration. Learn more about Shook's regulatory counseling capabilities at https://www.shb.com/services/practices/fda-and-regulatory-guidance

Featured:
Adrienne Byard: https://www.shb.com/professionals/b/byard-adrienne
Kristin Kaplan: https://www.shb.com/professionals/k/kaplan-kristin
----------------------------
The choice of a lawyer is an important decision and should not be based solely upon advertisements.
----------------------------
©Shook, Hardy & Bacon L.L.P. All rights reserved.

How can the PREP Act help protect healthcare providers from litigation during the COVID-19 pandemic? Learn more from Shook Partners Melissa Siebert and Anna Pieschel. Visit our PREP Act Intelligence Hub for more.

Shook Partner Lindsey Heinz and Associate Elizabeth Fessler discuss the regulatory and legal implications of food advertising, especially through social media. What types of scientific substantiation do companies need to supply for labeling claims, particularly those related to health and safety? Does FDA look beyond the product label to websites and social media when reviewing product for regulatory compliance? What should companies know about retweeting or sharing third-party endorsements?

Effectively communicating complex issues to a jury during a trial can be difficult, and the advanced technologies at issue in life sciences cases only complicate things further. Shook Partners Hildy Sastre and Hassia Diolombi discuss how their years of experience in the courtroom inform their abilities to boil down difficult issues for a jury.

Shook's AI white paper uncovered some unease among in-house counsel about implementing artificial intelligence into their businesses. Shook Partner Cory Fisher wants to help, whether that means providing counsel on potential legal liabilities or reassuring clients that AI can be manageable. Listen as he sheds additional light on the task force's findings.